How to manage refractory GERD. (Q37017109)

17 August 2017

1 reference

title

How to manage refractory GERD. (English)

1 reference

17 August 2017

Joel E Richter

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Nature Reviews Gastroenterology & Hepatology

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

658-664

1 reference

The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Patterns of proton pump inhibitor use in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

The role of esophageal pH monitoring in symptomatic patients on PPI therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Ambulatory esophageal pH monitoring using a wireless system

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Pill-induced esophageal injury: endoscopic features and clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Esophageal manifestations of dermatologic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Lichen planus esophagitis: report of three patients treated with oral tacrolimus or intraesophageal corticosteroid injections or both

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Reflux esophagitis in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Risk factors for esophagitis in extreme acid hypersecretors with and without Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Eosinophilic esophagitis: it's not just kid's stuff

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Association of eosinophilic inflammation with esophageal food impaction in adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

An etiological role for aeroallergens and eosinophils in experimental esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

The ringed esophagus: histological features of GERD.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Tolerance to oral H2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

The role of acid and duodenal gastroesophageal reflux in symptomatic GERD

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Functional esophageal disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Functional heartburn: the stimulus, the pain, and the brain

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Basic and clinical aspects of visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0979

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0979

1 reference

17 August 2017

1 reference